P53 modulates homologous recombination at I-SceI-induced double-strand breaks through cell-cycle regulation

Oncogene

Volumn 32, Issue 8, 2013, Pages 968-975

  Rieckmann, T ^a   Kriegs, M ^a   Nitsch, L ^a   Hoffer, K ^a   Rohaly, G ^b   Kocher, S ^a,c   Petersen, C ^a   Dikomey, E ^a   Dornreiter, I ^b   Dahm Daphi, J ^a,c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

cell cycle; homologous recombination; p53

Indexed keywords

MUTANT PROTEIN; PROTEIN P53;

ANIMAL CELL; ARTICLE; CELL CYCLE REGULATION; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; G1 PHASE CELL CYCLE CHECKPOINT; GENE REPRESSION; GENETIC TRANSFECTION; HOMOLOGOUS RECOMBINATION; NONHUMAN; PRIORITY JOURNAL; TRANSACTIVATION;

ANIMALS; CELL CYCLE CHECKPOINTS; CELL LINE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA BREAKS, DOUBLE-STRANDED; G2 PHASE; HOMOLOGOUS RECOMBINATION; HUMANS; S PHASE; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84874781345     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.123     Document Type: Article

References (37)

1. van Gent DC, Hoeijmakers JH, Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat Rev 2001; 2: 196-206.
2. Albertson DG, Collins C, McCormick F, Gray JW. Chromosome aberrations in solid tumors. Nat Genet 2003; 34: 369-376.
3. Bertrand P, Saintigny Y, Lopez BS. p53's double life: transactivation-independent repression of homologous recombination. Trends Genet 2004; 20: 235-243.
4. Gatz SA, Wiesmuller L. p53 in recombination and repair. Cell Death Differ 2006; 13: 1003-1016.
5. Bertrand P, Rouillard D, Boulet A, Levalois C, Soussi T, Lopez BS. Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein. Oncogene 1997; 14: 1117-1122.
6. Mekeel KL, Tang W, Kachnic LA, Luo CM, DeFrank JS, Powell SN. Inactivation of p53 results in high rates of homologous recombination. Oncogene 1997; 14: 1847-1857.
7. Wiesmuller L, Cammenga J, Deppert WW. In vivo assay of p53 function in homologous recombination between simian virus 40 chromosomes. J Virol 1996; 70: 737-744.
8. Boehden GS, Akyuz N, Roemer K, Wiesmuller L. p53 mutated in the transactivation domain retains regulatory functions in homology-directed double-strand break repair. Oncogene 2003; 22: 4111-4117.
9. Romanova LY, Willers H, Blagosklonny MV, Powell SN. The interaction of p53 with replication protein A mediates suppression of homologous recombination. Oncogene 2004; 23: 9025-9033.
10. Sturzbecher HW, Donzelmann B, Henning W, Knippschild U, Buchhop S. p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J 1996; 15: 1992-2002.
11. Linke SP, Sengupta S, Khabie N, Jeffries BA, Buchhop S, Miska S, et al. p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res 2003; 63: 2596-2605.
12. Yoon D, Wang Y, Stapleford K, Wiesmuller L, Chen J. P53 inhibits strand exchange and replication fork regression promoted by human Rad51. J Mol Biol 2004; 336: 639-654.
13. Lee S, Cavallo L, Griffith J. Human p53 binds holliday junctions strongly and facilitates their cleavage. J Biol Chem 1997; 272: 7532-7539.
14. Dudenhoffer C, Rohaly G, Will K, Deppert W, Wiesmuller L. Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination. Mol Cell Biol 1998; 18: 5332-5342.
15. Susse S, Janz C, Janus F, Deppert W, Wiesmuller L. Role of heteroduplex joints in the functional interactions between human Rad51 and wild-type p53. Oncogene 2000; 19: 4500-4512.
16. Bunz F, Fauth C, Speicher MR, Dutriaux A, Sedivy JM, Kinzler KW, et al. Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res 2002; 62: 1129-1133.
17. Sengupta S, Linke SP, Pedeux R, Yang Q, Farnsworth J, Garfield SH, et al. BLM helicase-dependent transport of p53 to sites of stalled DNA replication forks modulates homologous recombination. EMBO J 2003; 22: 1210-1222.
18. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science (New York, NY) 1992; 256: 827-830.
19. Joerger AC, Fersht AR. Structural biology of the tumor suppressor p53. Ann Rev Biochem 2008; 77: 557-582.
20. Akyuz N, Boehden GS, Susse S, Rimek A, Preuss U, Scheidtmann KH, et al. DNA substrate dependence of p53-mediated regulation of double-strand break repair. Mol Cell Biol 2002; 22: 6306-6317.
21. Dudenhoffer C, Kurth M, Janus F, Deppert W, Wiesmuller L. Dissociation of the recombination control and the sequence-specific transactivation function of P53. Oncogene 1999; 18: 5773-5784.
22. Saintigny Y, Lopez BS. Homologous recombination induced by replication inhibition, is stimulated by expression of mutant p53. Oncogene 2002; 21: 488-492.
23. Saintigny Y, Rouillard D, Chaput B, Soussi T, Lopez BS. Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint. Oncogene 1999; 18: 3553-3563.
24. Mansour WY, Schumacher S, Rosskopf R, Rhein T, Schmidt-Petersen F, Gatzemeier F, et al. Hierarchy of nonhomologous end-joining, single-strand annealing and gene conversion at site-directed DNA double-strand breaks. Nucleic Acids Res 2008; 36: 4088-4098.
25. Soutoglou E, Dorn JF, Sengupta K, Jasin M, Nussenzweig A, Ried T, et al. Positional stability of single double-strand breaks in mammalian cells. Nat Cell Biol 2007; 9: 675-682.
26. Kriegs M, Kasten-Pisula U, Rieckmann T, Holst K, Saker J, Dahm-Daphi J, et al. The epidermal growth factor receptor modulates DNA double-strand break repair by regulating non-homologous end-joining. DNA Repair 2010; 9: 889-897.
27. Sartori AA, Lukas C, Coates J, Mistrik M, Fu S, Bartek J, et al. Human CtIP promotes DNA end resection. Nature 2007; 450: 509-514.
28. Huertas P, Jackson SP. Human CtIP mediates cell cycle control of DNA end resection and double strand break repair. J Biol Chem 2009; 284: 9558-9565.
29. Restle A, Farber M, Baumann C, Bohringer M, Scheidtmann KH, Muller-Tidow C et al. Dissecting the role of p53 phosphorylation in homologous recombination provides new clues for gain-of-function mutants. Nucleic Acids Res 2008; 36: 5362-5375.
30. Willers H, McCarthy EE, Wu B, Wunsch H, Tang W, Taghian DG, et al. Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control. Oncogene 2000; 19: 632-639.
31. Johnson TM, Hammond EM, Giaccia A, Attardi LD. The p53QS transactivationdeficient mutant shows stress-specific apoptotic activity and induces embryonic lethality. Nat Genet 2005; 37: 145-152.
32. You Z, Shi LZ, Zhu Q, Wu P, Zhang YW, Basilio A, et al. CtIP links DNA doublestrand break sensing to resection. Mol Cell 2009; 36: 954-969.
33. Eid W, Steger M, El-Shemerly M, Ferretti LP, Pena-Diaz J, Konig C, et al. DNA end resection by CtIP and exonuclease 1 prevents genomic instability. EMBO Rep 2010; 11: 962-968.
34. Kaidi A, Weinert BT, Choudhary C, Jackson SP. Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science (New York, NY) 2010; 329: 1348-1353.
35. Roemer K, Mueller-Lantzsch N. p53 transactivation domain mutant Q22, S23 is impaired for repression of promoters and mediation of apoptosis. Oncogene 1996; 12: 2069-2079.
36. Zhang Y, Xiong Y. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science (New York, NY) 2001; 292: 1910-1915.
37. Tang M, Wahl GM, Nister M. Explaining the biological activity of transactivationdeficient p53 variants. Nat Genet 2006; 38: 395-396 author reply 6-7.